#NSE0046– Apollo Hospital, founded by Dr. Prathap C Reddy in 1983, stands as a hallmark of modern healthcare in India. From its inception as the nation’s first corporate hospital, Apollo has evolved into Asia’s leading integrated healthcare services provider. Its footprint spans across various crucial components of healthcare, including hospitals, pharmacies, primary care and diagnostic clinics, as well as several innovative retail health models.
The company’s remarkable journey is also reflected in its financial strength, with a market capitalization of ₹84,907 crores. This solid financial standing is further evidenced by its stock price-to-earnings ratio (P/E) of 108, indicating investor confidence in its growth potential and operational excellence.
Apollo Hospitals boasts a comprehensive network comprising 43 owned hospitals and 6 managed hospitals, totaling over 9500 beds. With a commendable occupancy rate of 62%, Apollo Hospitals serves a significant number of patients across its facilities. The average revenue per occupied bed (ARPOB) stands at Rs. 57,760 per day, indicating the revenue generated per patient bed utilized.
In addition to its hospital facilities, Apollo operates 22 ambulatory care and birthing centers, providing specialized care and services. The company also manages over 2000 diagnostics centers, ensuring accessibility to diagnostic services for patients across regions. Complementing these are 350+ clinics, offering primary care and specialized treatments, along with 120+ dialysis centers catering to patients with renal care needs. Moreover, Apollo Hospitals extends its services to dental care, with over 133 dental centers ensuring oral healthcare accessibility.
Apollo Hospitals’ reach extends far beyond its hospital facilities. With over 5600 outlets, including pharmacies and retail health models, it ensures accessibility to healthcare products and services across diverse locations. The significant expansion of 2083 outlets in FY23 reflects the company’s commitment to enhancing its presence and serving more communities.
Furthermore, Apollo Hospitals boasts a substantial user base, with approximately 27 million registered users benefiting from its services and offerings. This extensive user network underscores the company’s reputation and trust among healthcare consumers.
The company’s medical expertise is reinforced by a team of over 6000 doctors, ensuring high-quality healthcare delivery and comprehensive patient care across its network. Additionally, Apollo Hospitals emphasizes affordability and accessibility through its private label and generic sales, accounting for approximately 16% of its total sales. Apollo Hospitals continues to demonstrate leadership and innovation in healthcare through its pioneering efforts in solid multi-organ transplantation, robotic surgery, and advanced cancer treatment.
In addition to transplantation, Apollo Hospitals has expanded its specialized robotic colorectal surgery program across six key cities in India, including Chennai, Hyderabad, Bangalore, Delhi, Mumbai, and Vishakhapatnam. Moreover, Apollo’s Proton Cancer Centre has introduced the first and largest Helical TomoTherapy program in Tamil Nadu, further solidifying its position as a leader in cancer care and treatment innovation.
The shareholding pattern of Apollo Hospitals reflects the confidence and interest of various investor categories in the company’s growth prospects and operational performance.
- Promoters hold a significant stake in the company, with their ownership standing at 29.33%. This indicates their strong belief in the business and their commitment to its long-term success.
- Foreign Institutional Investors (FIIs) have also shown considerable interest in Apollo Hospitals, with their shareholding representing a substantial 45.63% of the total ownership. This indicates international investor confidence in the company’s growth trajectory and potential for generating returns.
- Domestic Institutional Investors (DIIs) hold a notable 19.55% stake in the company, reflecting the confidence of domestic institutional investors such as mutual funds, insurance companies, and other financial institutions in Apollo Hospitals’ performance and future prospects.
- The public, including retail investors, holds a 5.26% stake in the company. This signifies the participation of individual investors in owning shares of Apollo Hospitals, drawn by its reputation and growth potential in the healthcare sector.
- Government ownership stands at 0.23%, indicating a minor but potentially strategic interest in the company’s operations, likely driven by its significance in the healthcare industry and its contribution to the economy.
Disclaimer-
It’s important to note that discussions like are for informational purposes only and should not be taken as specific We are not SEBI registered investment advisor. Whether analyzing a company’s financial health, examining market trends, or discussing technical chart patterns, the goal is to provide insights and perspectives that can help you make more informed decisions according to your own research and investment strategy. Always consider consulting with a financial advisor or conducting thorough personal research before making any investment decisions.
